https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=28631985&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 286319852017103020171030
1557-86741862017Aug/SepSurgical infectionsSurg Infect (Larchmt)Effect of a Standardized Protocol of Antibiotic Therapy on Surgical Site Infection after Laparoscopic Surgery for Complicated Appendicitis.684688684-68810.1089/sur.2017.028Although it is accepted that complicated appendicitis requires antibiotic therapy to prevent post-operative surgical infections, consensus protocols on the duration and regimens of treatment are not well established. This study aimed to compare the outcome of post-operative infectious complications in patients receiving old non-standardized and new standard antibiotic protocols, involving either 5 or 10 days of treatment, respectively.We enrolled 1,343 patients who underwent laparoscopic surgery for complicated appendicitis between January 2009 and December 2014. At the beginning of the new protocol, the patients were divided into two groups; 10 days of various antibiotic regimens (between January 2009 and June 2012, called the non-standardized protocol; n = 730) and five days of cefuroxime and metronidazole regimen (between July 2012 and December 2014; standardized protocol; n = 613). We compared the clinical outcomes, including surgical site infection (SSI) (superficial and deep organ/space infections) in the two groups.The standardized protocol group had a slightly shorter operative time (67 vs. 69 min), a shorter hospital stay (5 vs. 5.4 d), and lower medical cost (US$1,564 vs. US$1,654). Otherwise, there was no difference between the groups. No differences were found in the non-standardized and standard protocol groups with regard to the rate of superficial infection (10.3% vs. 12.7%; p = 0.488) or deep organ/space infection (2.3% vs. 2.1%; p = 0.797).In patients undergoing laparoscopic surgery for complicated appendicitis, five days of cefuroxime and metronidazole did not lead to more SSIs, and it decreased the medical costs compared with non-standardized antibiotic regimens.ParkHyoung-ChulHCDepartment of Surgery, Hallym University College of Medicine , Anyang, Republic of Korea.KimMin JeongMJDepartment of Surgery, Hallym University College of Medicine , Anyang, Republic of Korea.LeeBong HwaBHDepartment of Surgery, Hallym University College of Medicine , Anyang, Republic of Korea.engJournal Article20170620
United StatesSurg Infect (Larchmt)98156421096-29640Anti-Bacterial Agents140QMO216EMetronidazoleO1R9FJ93EDCefuroximeIMAdultAnti-Bacterial Agentsadministration & dosagetherapeutic useAppendicitissurgeryCefuroximeadministration & dosagetherapeutic useFemaleHumansLaparoscopyadverse effectsMaleMetronidazoleadministration & dosagetherapeutic useMiddle AgedRetrospective StudiesSurgical Wound Infectiondrug therapyepidemiologyantibiotic therapycomplicated appendicitissurgical site infection
2017621602017103160201762160ppublish2863198510.1089/sur.2017.028